In summary, antiviral T cells reactive against PepTivator SARS-CoV-2 Select were detectable in convalescent COVID-19 patients and these were mainly TNF-α and IFN-γ producing CD8+ and CD4+ T cells. This evidence concerns the gene CD8A and COVID-19.